supply of oncology ( drugs ) , dept of oncology ( drugs ) , inj carboplatin 150 mg , inj vinorelbine 50 mg , inj vinorelbine 10 mg , inj bleomycin sulphate 15 mg , inj cyclophosphamide 500 mg , inj cytosine arabinoside ( cytarabine ) 500 mg , inj doxorubicin hcl 2mg / ml , 5 ml inj , inj etoposide 100 mg , 5 ml inj , inj ifosfamide 1 gm vial with 2 amp of 2 ml each mesna , inj gemcitabine 1000 mg , inj methotrexate 15 mg intrathecal 3 ml inj , inj rituximab 500 mg , inj mesna 200 mg , inj nano particle albumin bound paclitaxel 100 mg , inj epirubicin 50 mg , tab aprepitant pack of 3 tab , inj methotrexate 500 mg , tab regorafenib 40 mg , tab erlotinib 150 mg , inj actinomycin d 0 . 5 mg , tab gefitinib 250 mg , inj irinotecan 100 mg , cao procarbazine hcl 50 mg , cap temozolamide 250 mg , inj leucovorin calcium 50 mg / ml , tab exemestane 25 mg , tab leucovorin 15 mg , tab everolimus 5 mg , inj cabzitaxel 60 mg , inj fosapripitant , inj fulvestrant 250 mg , inj vinblastine sulphate 10 mg , cap tegafur uracil 100 / 224 mg , inj bendamustine 100 mg , inj trastuzumab 440 mg , inj pegylated liposomal doxorubicin 20 mg , cap enzalutamide 40 mg , granulocyte colony stimulating factor 300 mcg